These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23386737)
1. The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma. Liu K; Peng W; Zhou Z Acta Radiol; 2013 May; 54(4):364-8. PubMed ID: 23386737 [TBL] [Abstract][Full Text] [Related]
2. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. Wang CL; Chea YW; Boll DT; Samei E; Neville AM; Dale BM; Merkle EM Eur J Radiol; 2011 Nov; 80(2):e1-7. PubMed ID: 20646887 [TBL] [Abstract][Full Text] [Related]
3. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171 [TBL] [Abstract][Full Text] [Related]
4. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions. Liu K; Xie P; Peng W; Zhou Z J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251 [TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging of brain tumors: a short temporal interval assessment. Li X; Qu JR; Luo JP; Li J; Zhang HK; Shao NN; Kwok K; Zhang SN; Li YL; Liu CC; Zee CS; Li HL J Magn Reson Imaging; 2014 Sep; 40(3):616-21. PubMed ID: 24925118 [TBL] [Abstract][Full Text] [Related]
6. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis. Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868 [TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. Chiu FY; Jao JC; Chen CY; Liu GC; Jaw TS; Chiou YY; Hsu FO; Hsu JS J Comput Assist Tomogr; 2005; 29(2):176-80. PubMed ID: 15772533 [TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging for pancreatic ductal adenocarcinoma at 3.0-T magnetic resonance: correlation with histopathology. Liu K; Xie P; Peng W; Zhou Z J Comput Assist Tomogr; 2015; 39(1):13-8. PubMed ID: 25340589 [TBL] [Abstract][Full Text] [Related]
10. Preoperative detection of small pancreatic carcinoma: value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level. Park MJ; Kim YK; Choi SY; Rhim H; Lee WJ; Choi D Radiology; 2014 Nov; 273(2):433-43. PubMed ID: 24991989 [TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T. Song KD; Kim YK; Lee WJ; Lee MW; Park MJ; Hwang J; Lee MH Acta Radiol; 2012 Jun; 53(5):485-93. PubMed ID: 22535883 [TBL] [Abstract][Full Text] [Related]
12. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216 [TBL] [Abstract][Full Text] [Related]
13. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. Lee MH; Kim SH; Park MJ; Park CK; Rhim H AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534 [TBL] [Abstract][Full Text] [Related]
14. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Jang KM; Kim SH; Lee SJ; Choi D Acta Radiol; 2014 Mar; 55(2):140-8. PubMed ID: 23897307 [TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging with fat suppression using short-tau inversion recovery: Clinical utility for diagnosis of breast lesions. Ouyang Z; Ouyang Y; Zhu M; Lu Y; Zhang Z; Shi J; Li X; Ren G Clin Radiol; 2014 Aug; 69(8):e337-44. PubMed ID: 24837698 [TBL] [Abstract][Full Text] [Related]
16. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. Saito K; Araki Y; Park J; Metoki R; Katsuyama H; Nishio R; Kakizaki D; Moriyasu F; Tokuuye K J Magn Reson Imaging; 2010 Jul; 32(1):229-34. PubMed ID: 20578029 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Johnson PT; Outwater EK Radiology; 1999 Jul; 212(1):213-8. PubMed ID: 10405744 [TBL] [Abstract][Full Text] [Related]
18. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008 [TBL] [Abstract][Full Text] [Related]
19. Effect of intravenous gadolinium-DTPA on diffusion-weighted images: evaluation of normal brain and infarcts. Yamada K; Kubota H; Kizu O; Nakamura H; Ito H; Yuen S; Tanaka O; Kubota T; Makino M; Van Cauteren M; Nishimura T Stroke; 2002 Jul; 33(7):1799-802. PubMed ID: 12105356 [TBL] [Abstract][Full Text] [Related]
20. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. Jang KM; Kim SH; Min JH; Lee SJ; Kang TW; Lim S; Choi D AJR Am J Roentgenol; 2014 Nov; 203(5):992-1000. PubMed ID: 25341136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]